Trials / Completed
CompletedNCT04768244
Impact of Maternal COVID-19 Disease on Breast Milk and Infant Health
Impact of Maternal SARS-CoV-2 Infection and Vaccination on Breast Milk Antibodies, Milk Bioactive Compounds and Maternal-child Health (MilkCORONA)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Institute of Agrochemistry and Food Technology, National Research Council · Other Government
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
prospective multicenter study The main aim is to study the impact of maternal COVID-19 on breast milk immune, microbiological, and metabolic profile and infant growth and development
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | maternal SARS-CoV-2 infection | positive PCR in nasopharinx and/or presence of antibodies in serum |
Timeline
- Start date
- 2020-04-01
- Primary completion
- 2023-03-31
- Completion
- 2023-10-10
- First posted
- 2021-02-24
- Last updated
- 2023-10-25
Locations
2 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT04768244. Inclusion in this directory is not an endorsement.